• Home
  • Technology
  • Gaming
  • Entertainment
  • World & Business
  • Science
  • Sports
  • AI
HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
Science
Report

GLP-1 drugs are increasingly marketed as a way to look and feel better

STAT reports a shift from promoting GLP-1 drugs as tools to address obesity as a medical issue toward a lifestyle pitch.

STATST
Bob HermanBH
2 Sources, 12d ago, first seen 12d ago

TLDR

STAT says GLP-1 drugs, once promoted as tools to address obesity as a medical issue, are increasingly being seen and marketed as a way to look and feel better.

Combined views

6.4K

2 Sources, first seen 12d ago

20 likes3 comments6 saves12 reposts

Combined views

6.4K

2 Sources, first seen 12d ago

20 likes3 comments6 saves12 reposts

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Featured Source

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Related

Novo Nordisk partners with Anthropic on AI for its scientists

Novo Nordisk says the partnership aims to help its scientists bring new medicines to patients faster.

2 Sources

STAT@statnewsOnce promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen — and marketed — as a way to look and feel better https://trib.al/sh3RVKP12d
Bob Herman@bobjhermanHealth insurers and employers are dialing back coverage of GLP-1s for weight loss due to the drugs' high prices and usage. Now, Eli Lilly and Novo Nordisk are marketing the drugs more to "customers" than to payers. Great read from @elaineywchen: https://www.statnews.com/2026/09/28/glp1-marketing-shift-obesity-medicine-weight-loss-drug/11d
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI
    Eli LillyNovo Nordisk

    2 Sources

    STAT@statnewsOnce promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen — and marketed — as a way to look and feel better https://trib.al/sh3RVKP12d
    Bob Herman@bobjhermanHealth insurers and employers are dialing back coverage of GLP-1s for weight loss due to the drugs' high prices and usage. Now, Eli Lilly and Novo Nordisk are marketing the drugs more to "customers" than to payers. Great read from @elaineywchen: https://www.statnews.com/2026/09/28/glp1-marketing-shift-obesity-medicine-weight-loss-drug/11d
    Today's Rank

    —

    Not ranked yet

    Today's Rank

    —

    Not ranked yet